477 related articles for article (PubMed ID: 18234028)
1. Substitution of vaccinia virus Elstree by modified vaccinia virus Ankara to test the virucidal efficacy of chemical disinfectants.
Hartnack S; Essbauer S; Truyen U
Zoonoses Public Health; 2008; 55(2):99-105. PubMed ID: 18234028
[TBL] [Abstract][Full Text] [Related]
2. Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants?
Rabenau HF; Rapp I; Steinmann J
BMC Infect Dis; 2010 Jun; 10():185. PubMed ID: 20573218
[TBL] [Abstract][Full Text] [Related]
3. Guidelines of Bundesgesundheitsamt (BGA; German Federal Health Office) and Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e.V. (DVV; German Association for the Control of Virus Diseases) for testing the effectiveness of chemical disinfectants against viruses.
Zentralbl Hyg Umweltmed; 1990 May; 189(6):554-6; discussion 557-62. PubMed ID: 2166529
[No Abstract] [Full Text] [Related]
4. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
5. [Development of a numerically additive combined vaccine against tetanus and smallpox].
Mayr A; Baljer G; Wagner C; Sailer J
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
[TBL] [Abstract][Full Text] [Related]
6. [Virucidal disinfection in gynecology].
von Rheinbaben F
Zentralbl Gynakol; 1992; 114(5):265-9. PubMed ID: 1626440
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
[TBL] [Abstract][Full Text] [Related]
8. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
Coulibaly S; Brühl P; Mayrhofer J; Schmid K; Gerencer M; Falkner FG
Virology; 2005 Oct; 341(1):91-101. PubMed ID: 16061267
[TBL] [Abstract][Full Text] [Related]
9. [Virucidal effectiveness of some commercial products for chemothermal disinfection methods for temperature resistant viruses and bacteriophages--evaluation of a test model].
von Rheinbaben F; Bansemir KP; Heinzel M
Zentralbl Hyg Umweltmed; 1992 Feb; 192(5):419-31. PubMed ID: 1313238
[TBL] [Abstract][Full Text] [Related]
10. Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA).
Abdalrhman I; Gurt I; Katz E
Vaccine; 2006 May; 24(19):4152-60. PubMed ID: 16603280
[TBL] [Abstract][Full Text] [Related]
11. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
McCurdy LH; Larkin BD; Martin JE; Graham BS
Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
[TBL] [Abstract][Full Text] [Related]
12. Does limited virucidal activity of biocides include duck hepatitis B virucidal action?
Sauerbrei A; Schacke M; Glück B; Bust U; Rabenau HF; Wutzler P
BMC Infect Dis; 2012 Oct; 12():276. PubMed ID: 23110658
[TBL] [Abstract][Full Text] [Related]
13. Suitability of two commercial preparations for disinfections against methicillin-resistant Staphylococcus aureus in veterinary medicine.
Yilmaz A; Kaleta EF
Dtsch Tierarztl Wochenschr; 2009 May; 116(5):180-5. PubMed ID: 19462641
[TBL] [Abstract][Full Text] [Related]
14. Tungsten carbide nanoparticles show a broad spectrum virucidal activity against enveloped and nonenveloped model viruses using a guideline-standardized in vitro test.
Pfaff F; Glück B; Hoyer T; Rohländer D; Sauerbrei A; Zell R
Lett Appl Microbiol; 2019 Oct; 69(4):302-309. PubMed ID: 31436888
[TBL] [Abstract][Full Text] [Related]
15. [Decision of the Technical Committee Virus Disinfection of the German Association against Virus Diseases Association (DVV) of 1 September 2010 on the exchange of vaccinia virus strain Elstree against the modified vaccinia Ankara (MVA) virus as a test under the Virus testing act according to the DVV / RKI guideline as amended on 01.08.2008.].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Oct; 53(10):1114. PubMed ID: 20936456
[No Abstract] [Full Text] [Related]
16. Comparative efficacy of replicating smallpox vaccine strains in a murine challenge model.
Phelps A; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
Vaccine; 2005 May; 23(27):3500-7. PubMed ID: 15855008
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine.
Vollmar J; Arndtz N; Eckl KM; Thomsen T; Petzold B; Mateo L; Schlereth B; Handley A; King L; Hülsemann V; Tzatzaris M; Merkl K; Wulff N; Chaplin P
Vaccine; 2006 Mar; 24(12):2065-70. PubMed ID: 16337719
[TBL] [Abstract][Full Text] [Related]
18. [Disinfectant tests at 20 and 10 degrees C to determine the virucidal activity against circoviruses].
Yilmaz A; Kaleta EF
Dtsch Tierarztl Wochenschr; 2004 Jun; 111(6):248-51. PubMed ID: 15287578
[TBL] [Abstract][Full Text] [Related]
19. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
Pittman PR; Hahn M; Lee HS; Koca C; Samy N; Schmidt D; Hornung J; Weidenthaler H; Heery CR; Meyer TPH; Silbernagl G; Maclennan J; Chaplin P
N Engl J Med; 2019 Nov; 381(20):1897-1908. PubMed ID: 31722150
[TBL] [Abstract][Full Text] [Related]
20. Transmission of vaccinia virus and rationale for measures for prevention.
Lane JM; Fulginiti VA
Clin Infect Dis; 2003 Jul; 37(2):281-4. PubMed ID: 12856220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
